海思科(002653.SZ)：HSK47388片获准开展临床试验

Group 1 - The company, Haikang Technology (002653.SZ), has received approval from the National Medical Products Administration for clinical trials of HSK47388 tablets [1] - The drug is intended for the treatment of autoimmune diseases [1]